Jessica Geiger, MD
Medical Oncology · Cleveland, OHNPI 1366763021
Payments from drug & device makers
Across 280 payments — averaging $8497.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$531K
- Regeneron$463K
- Alkermes, Inc.$412K
- Janssen Research & Development, LLC$389K
- Merck Healthcare Kgaa$170K
- Merck$132K
- plus $283K from 11 others
Across 31 payments — averaging $199.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$5K
- Astellas Pharma Global Development$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 19 | $530,557 |
| Regeneron | 77 | $462,608 |
| Alkermes, Inc. | 13 | $412,096 |
| Janssen Research & Development, LLC | 26 | $388,960 |
| Merck Healthcare Kgaa | 23 | $170,027 |
| Merck | 7 | $132,152 |
| Astellas Pharma Global Development | 66 | $120,498 |
| Modernatx, Inc. | 20 | $93,347 |
| EMD Serono, Inc. | 7 | $57,427 |
| Janssen Scientific Affairs, LLC | 3 | $5,370 |
| Coherus Oncology, Inc. | 2 | $2,388 |
| Exelixis Inc. | 1 | $1,980 |
| Merck Kgaa | 1 | $690 |
| F. Hoffmann-la Roche AG | 2 | $552 |
| Taiho Oncology, Inc. | 6 | $242 |
| AstraZeneca | 6 | $165 |
| Tactile Systems Technology Inc | 1 | $144 |
How this compares
$2,379,202 in reported general payments places this provider in the 85th percentile of 157 medical oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Cleveland
- Jennifer SelfridgeCleveland$6.3M
- Moshe OrnsteinCleveland$6.1M
- David PeereboomCleveland$3.4M
- Wen MaCleveland$2.4M
- Lucy KennedyCleveland$796K
- William TseCleveland$731K
- Khaled HassanCleveland$562K
- Suneel KamathCleveland$463K
- George BuddCleveland$407K
- Lauren ChiecCleveland$375K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.